Suspended lead suit and physician radiation doses during coronary angiography

Objective This study was performed to evaluate physician radiation doses with the use of a suspended lead suit. Background Interventional cardiologists face substantial occupational risks from chronic radiation exposure and wearing heavy lead aprons. Methods Head‐level physician radiation doses, col...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Catheterization and cardiovascular interventions 2022-03, Vol.99 (4), p.981-988
Hauptverfasser: Salcido‐Rios, Jose, McNamara, David A., VanOosterhout, Stacie, VanLoo, Lisa, Redmond, Meaghan, Parker, Jessica L., Madder, Ryan D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective This study was performed to evaluate physician radiation doses with the use of a suspended lead suit. Background Interventional cardiologists face substantial occupational risks from chronic radiation exposure and wearing heavy lead aprons. Methods Head‐level physician radiation doses, collected using real‐time dosimeters during consecutive coronary angiography procedures, were compared with the use of a suspended lead suit versus conventional lead aprons. Multiple linear regression analyses were completed using physician radiation doses as the response and testing patient variables (body mass index, age, sex), procedural variables (right heart catheterization, fractional flow reserve, percutaneous coronary intervention, radial access), and shielding variables (radiation‐absorbing pad, accessory lead shield, suspended lead suit) as the predictors. Results Among 1054 coronary angiography procedures, 691 (65.6%) were performed with a suspended lead suit and 363 (34.4%) with lead aprons. There was no significant difference in dose area product between groups (61.7 [41.0, 94.9] mGy·cm2 vs. 64.6 [42.9, 96.9] mGy·cm2, p = 0.20). Median head‐level physician radiation doses were 10.2 [3.2, 35.5] μSv with lead aprons and 0.2 [0.1, 0.9] μSv with a suspended lead suit (p 
ISSN:1522-1946
1522-726X
DOI:10.1002/ccd.30047